A Study To Examine The Safety, Tolerability And Pharmacokinetics Of PF-04958242 In Psychiatrically Stable Subjects With Schizophrenia
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 40
Summary
- Conditions
- Schizophrenia
- Type
- Interventional
- Phase
- Phase 1
- Design
- Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: Double (Participant, Investigator)Primary Purpose: Basic Science
Participation Requirements
- Age
- Between 18 years and 55 years
- Gender
- Both males and females
Description
This study was previously posted by Pfizer, Inc. Sponsorship of the trial was transferred to Biogen.
This study was previously posted by Pfizer, Inc. Sponsorship of the trial was transferred to Biogen.
Tracking Information
- NCT #
- NCT01518894
- Collaborators
- Not Provided
- Investigators
- Study Director: Medical Director Biogen
Get Well Soon